Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link



Dow Jones Industrial Average



) is trading up 39 points (+0.2%) at 16,103 as of Monday, Nov 25, 2013, 10:35 a.m. ET. During this time, 80.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 378.9 million. The NYSE advances/declines ratio sits at 1,362 issues advancing vs. 1,502 declining with 139 unchanged.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is

International Business Machines


TheStreet Recommends


), which is lagging the broader Dow index with a $1.45 decline (-0.8%) bringing the stock to $179.85. Volume for International Business Machines currently sits at 2.7 million shares traded vs. an average daily trading volume of 4.6 million shares.

International Business Machines has a market cap of $199.94 billion and is part of the technology sector and computer software & services industry. Shares are down 5.3% year to date as of Friday's close. The stock's dividend yield sits at 2.1%.

International Business Machines Corporation provides information technology (IT) products and services worldwide. The company has a P/E ratio of 12.8, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates International Business Machines as a


. The company's strengths can be seen in multiple areas, such as its increase in net income, notable return on equity, expanding profit margins, growth in earnings per share and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more